Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
The European Journal of Health Economics
Published in: The European Journal of Health Economics 3/2008

01-08-2008 | Original paper

An assessment of the discriminative ability of the EQ-5Dindex, SF-6D, and EQ VAS, using sociodemographic factors and clinical conditions

Authors: Garry R. Barton, Tracey H. Sach, Michael Doherty, Anthony J. Avery, Claire Jenkinson, Kenneth R. Muir

Published in: The European Journal of Health Economics | Issue 3/2008

Login to get access

Abstract

Objective

To assess whether three health-related quality-of-life (HRQL) measures (the EQ-5Dindex, SF-6D, and EQ VAS) can discriminate between the HRQL of different groups of individuals.

Methods

In one UK general practice a cross-sectional survey requested information on six sociodemographic factors, 10 clinical conditions, and the three HRQL measures. Regression analyses were used to assess whether there was a significant difference in HRQL between groups with different sociodemographic factors and those with and without clinical conditions.

Results

One thousand eight hundred and sixty-five questionnaires were returned. There was a significant difference between the HRQL of the majority of different groups according to each HRQL measure. However, not all of the measures could discriminate between groups of different ethnicity, gender, or smoking status, or those with and without asthma, stroke, cancer or diabetes.

Conclusion

The HRQL of the majority of different groups could be discriminated between by the EQ-5Dindex, SF-6D, and EQ VAS.
Literature
1.
Streiner, D.L., Norman, G.R.: Health Measurement Scales: A Practical Guide to Their Development and Use (3rd edn). Oxford University Press, New York (2003)
2.
Brazier, J.E., Deverill, M., Green, C., Harper, R., Booth, A.: A review of the use of health status measures in economic evaluation. Health Technol. Assess. 3, 1–164 (1999)
3.
Brooks, R.: EuroQol: the current state of play. Health Policy 37, 53–72 (1996)CrossRef
4.
Brazier, J.E., Roberts, J., Deverill, M.: The estimation of a preference-based measure of health from the SF-36. J. Health Econ. 21, 271–292 (2002)CrossRef
5.
Marra, C.A., Esdaile, J.M., Guh, D., Kopec, J.A., Brazier, J.E., Koehler, B.E., Chalmers, A., Anis A.H.: A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. Med. Care 42, 1125–1131 (2004)CrossRef
6.
Petrou, S., Hockley, C.: An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Econ. 14, 1169–1189 (2005)CrossRef
7.
Macran, S., Weatherly, H., Kind, P.: Measuring population health: a comparison of three generic health status measures. Med. Care 41, 218–231 (2003)CrossRef
8.
Johnson, J.A., Coons, S.J.: Comparison of the EQ-5D and SF-12 in an adult US sample. Qual. Life Res. 7, 155–166 (1998)CrossRef
9.
Lamers, L.M., Bouwmans, C.A.M., van Straten, A., Donker, M.C.H., Hakkaart, L.: Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Econ. 15, 1229–1236 (2006)CrossRef
10.
Johnson, J.A., Pickard, A.S.: Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada. Med. Care 38, 115–121 (2000)CrossRef
11.
Luo, N., Johnson, J.A., Shaw, J.W., Feeny, D., Coons, S.J.: Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Med. Care 43, 1078–1086 (2005)CrossRef
12.
Kind, P., Dolan, P., Gudex, C., Williams, A.: Variations in population health status: results from a UK national questionnaire survey. BMJ 316, 736–741 (1998)
13.
Lubetkin, E.I., Jia, H., Gold, M.R.: Construct validity of the EQ-5D in low-income Chinese American primary care patients. Qual. Life Res. 13, 1459–1468 (2004)CrossRef
14.
Sullivan, P.W., Lawence, W.F., Ghushchyan, V.: A national catalog of preference-based scores for chronic conditions in the United States. Med. Care 43, 736–749 (2005)CrossRef
15.
Lubetkin, E.I., Jia, H., Franks, P., Gold, M.R.: Relationship among sociodemographic factors, clinical conditions, and health-related quality of life: examining the EQ-5D in the U.S. general population. Qual. Life Res. 14, 2187–2196 (2005)CrossRef
16.
Ware, J.E., Sherbourne, C.: The MOS 36 item short-form health survey: conceptual framework and item selection. Med. Care 30, 473–483 (1992)CrossRef
17.
Brazier, J.E.: The SF-36 health survey questionnaire—a tool for economists. Health Econ. 2, 213–215 (1993)CrossRef
18.
Johnson, J.A., Connolly, M., Zuberbuhler, P., Brown, N.E.: Health-related quality of life for adults with cystic fibrosis: a regression approach to assessing the impact of recombinant human DNase. Pharmacotherapy 20, 1167–1174 (2000)CrossRef
19.
Jia, H., Lubetkin, E.I.: The impact of obesity on health-related quality-of-life in the general adult US population. J Public Health (Oxf) 27, 156–164 (2005)CrossRef
20.
Macran, S.: The relationship between body mass index and health-related quality of life (Discussion Paper 190). University of York: Centre for Health Economics (2004)
21.
Office for National Statistics: Standard occupational classification 2000 (Volume 2): the coding index. The Stationery Office, London (2000)
22.
Claxton, K.: The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J. Health Econ. 18, 341–364 (1999)CrossRef
23.
Jaeschke, R., Singer, J., Guyatt, G.H.: Measurement of health status: ascertaining the minimal clinical important difference. Control Clin. Trials 10, 407–415 (1989)CrossRef
24.
Walters S.J., Brazier J.E.: Comparison of the minimally important difference for two health state utility measures: EQ-5D, SF-6D. Qual Life Res 14, 1523–1532 (2005)CrossRef
25.
Marra C.A., Woolcott J.C., Kopec J.A., Shojania K., Offer R., Brazier J.E., Esdaile J.M., Anis A.H.: A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc. Sci. Med. 60, 1571–1582 (2005)CrossRef
26.
Walters, S.J., Brazier, J.E.: What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual. Life Outcomes 1, 4 (2003)CrossRef
27.
WHO: Obesity: preventing and managing the global epidemic. Report of a WHO consultation on Obesity. WHO, Geneva (2001)
28.
National Institutes of Health: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in Adults—the evidence report. Obes. Res. 6, 51S–209S (1998)
29.
Torrance, G.W.: Measurement of health state utilities for economic appraisal. J. Health Econ. 5, 1–30 (1986)CrossRef
30.
Dolan, P., Gudex, C., Kind, P., Williams, A.: A social tariff for the EuroQol: results from a UK general population survey (Discussion Paper 138). University of York:Centre for Health Economics (1995)
31.
Gerard, K., Nicholson, T., Mullee, M., Mehta, R., Roderick, P.: EQ-5D versus SF-6D in an older, chronically ill patient group. Appl. Health Econ. Health Policy 3, 91–102 (2004)CrossRef
32.
Dolan, P., Gudex, C., Kind, P., Williams, A.: Valuing health states: a comparison of methods. J. Health Econ. 15, 209–231 (1996)CrossRef
33.
Badia, X., Roset, M., Herdman, M.: Inconsistent responses in three preference-elicitation methods for health states. Soc. Sci. Med. 49, 943–950 (1999)CrossRef
34.
Brazier, J.E., Roberts, J., Tsuchiya, A., Busschbach, J.: A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ. 13, 873–884 (2004)CrossRef
35.
Fenwick, E., Claxton, K., Sculpher, M.J.: Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ. 10, 779–787 (2001)CrossRef
36.
Walters, S.J., Campbell, M.J.: The use of bootstrap methods for analysing health-related quality of life outcomes (particularly the SF-36). Health Qual. Life Outcomes 2, 70 (2004)CrossRef
37.
Wooldridge, J.M.: Introductory Econometrics: A Modern Approach. Thomson South-Western, Mason (2006)
38.
Conner-Spady, B., Suarez-Almazor, M.E.: Variation in the estimation of quality-adjusted life-years by different preference-based instruments. Med. Care. 41, 791–801 (2003)CrossRef
39.
Barton, G.R., Bankart, J., Davis, A.C., Summerfield, A.Q.: Comparing utility scores before and after hearing-aid provision: Results according to the EQ-5D, HUI3 and SF-6D. Appl. Health Econ. Health Policy 3, 103–105 (2004)CrossRef
40.
Longworth, L., Bryan, S.: An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Econ. 12, 1061–1067 (2003)CrossRef
41.
Pickard, A.S., Johnson, J.A., Feeny, D.H.: Responsiveness of generic health-related quality of life measures in stroke. Qual. Life Res. 14, 207–219 (2005)CrossRef
42.
Lenert, L., Kaplan, R.M.: Validity and interpretation of preference-based measures of health-related quality of life. Med. Care 38(Supplement 2), 138–150 (2000)
43.
Drummond, M.: Introducing economic and quality of life measurements into clinical studies. Ann Med 33, 344–349 (2001)CrossRef
44.
Hurst, N.P., Kind, P., Ruta, D., Hunter, M., Stubbings, A.: Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Rheumatology (Oxford) 36, 551–559 (1997)CrossRef
45.
Sach, T.H., Barton, G.R.: Interpreting parental proxy reports of (health-related) quality of life for children with unilateral cochlear implants. Int. J. Pediatr. Otorhinolaryngol. 17, 435–445 (2007)CrossRef
46.
Maddigan, S.L., Feeny, D.H., Johnson, J.A.: Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey. Qual. Life Res. 14, 1311–1320 (2005)CrossRef
47.
Wu, S.C., Li, C.Y., Ke, D.S.: The agreement between self-reporting and clinical diagnosis for selected medical conditions among the elderly in Taiwan. Public Health 114, 137–142 (2000)CrossRef
48.
Cartwright, A.: Who responds to postal questionnaires? J. Epidemiol. Community Health 40, 267–273 (1986)CrossRef
49.
McColl, E., Jacoby, A., Thomas, L., Soutter, J., Bamford, C., Steen, N., Thomas, R., Harvey, E., Garratt, A., Bond, J.: Design and use of questionnaires: a review of best practice applicable to surveys of health service staff and patients. Health Technol. Assess. 5, 1–256 (2001)
50.
Fitzpatrick, R., Davey, C., Buxton, M.J., Jones, D.R.: Criteria for assessing patient based outcome measures for use in clinical trials. Health Technol. Assess. 2(14), 1–74 (1998)
Metadata
Title
An assessment of the discriminative ability of the EQ-5Dindex, SF-6D, and EQ VAS, using sociodemographic factors and clinical conditions
Authors
Garry R. Barton
Tracey H. Sach
Michael Doherty
Anthony J. Avery
Claire Jenkinson
Kenneth R. Muir
Publication date
01-08-2008
Publisher
Springer-Verlag
Published in
The European Journal of Health Economics / Issue 3/2008
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-007-0068-z

Other articles of this Issue 3/2008

The European Journal of Health Economics 3/2008 Go to the issue

Original paper

Economic consequences of near-patient test results: the case of tests for the Helicobacter Pylori bacterium in dyspepsia

Original paper

A theoretical and empirical investigation of nutritional label use

Original paper

The cost of treating high blood pressure in general practice in France

Original paper

Predisposing factors for early retirement in patients with Schizophrenia in Germany

Editorial

IQWiG: an opportunity lost?

Original paper

Preferences and utilities for the symptoms of moderate to severe allergic asthma